122 results on '"de Pedro, Nuria"'
Search Results
102. Daily changes in thyroid activity in the frog Rana perezi: Variation with season
- Author
-
Gancedo, Begoña, primary, Alonso-Gómez, Angel Luis, additional, de Pedro, Nuria, additional, Delgado, María Jesús, additional, and Alonso-Bedate, Mercedes, additional
- Published
- 1996
- Full Text
- View/download PDF
103. Mu-opioid receptor is involved in β-endorphin-induced feeding in goldfish
- Author
-
De Pedro, Nuria, primary, Céspedes, María Virtudes, additional, Delgado, María Jesús, additional, and Alonso-Bedate, Mercedes, additional
- Published
- 1996
- Full Text
- View/download PDF
104. The galanin-induced feeding stimulation is mediated via α2-adrenergic receptors in goldfish
- Author
-
de Pedro, Nuria, primary, Céspedes, María Virtudes, additional, Delgado, María Jesús, additional, and Alonso-Bedate, Mercedes, additional
- Published
- 1995
- Full Text
- View/download PDF
105. Central administration of β-endorphin increases food intake in goldfish: pretreatment with the opioid antagonist naloxone
- Author
-
de Pedro, Nuria, primary, Delgado, María Jesús, additional, and Alonso-Bedate, Mercedes, additional
- Published
- 1995
- Full Text
- View/download PDF
106. Role of corticotropin-releasing factor (CRF) as a food intake regulator in goldfish
- Author
-
De Pedro, Nuria, primary, Alonso-Gómez, Angel Luis, additional, Gancedo, Begoǹa, additional, Delgado, María Jesús, additional, and Alonso-Bedate, Mercedes, additional
- Published
- 1993
- Full Text
- View/download PDF
107. Synthesis of Trichodermin Derivatives and Their Antimicrobial and Cytotoxic Activities
- Author
-
Microbiologia, Barúa Chamorro, Javier E., de la Cruz Moreno, Mercedes, de Pedro, Nuria, Cautain, Bastien, Hermosa, Rosa, Cardoza, Rosa E., Gutiérrez Martín, Santiago, Monte Vázquez, Enrique, Vicente Pérez, María Francisca, Collado, Isidro G., Microbiologia, Barúa Chamorro, Javier E., de la Cruz Moreno, Mercedes, de Pedro, Nuria, Cautain, Bastien, Hermosa, Rosa, Cardoza, Rosa E., Gutiérrez Martín, Santiago, Monte Vázquez, Enrique, Vicente Pérez, María Francisca, and Collado, Isidro G.
- Abstract
[EN] Trichothecene mycotoxins are recognized as highly bioactive compounds that can be used in the design of new useful bioactive molecules. In Trichoderma brevicompactum, the first specific step in trichothecene biosynthesis is carried out by a terpene cyclase, trichodiene synthase, that catalyzes the conversion of farnesyl diphosphate to trichodiene and is encoded by the tri5 gene. Overexpression of tri5 resulted in increased levels of trichodermin, a trichothecene-type toxin, which is a valuable tool in preparing new molecules with a trichothecene skeleton. In this work, we developed the hemisynthesis of trichodermin and trichodermol derivatives in order to evaluate their antimicrobial and cytotoxic activities and to study the chemo-modulation of their bioactivity. Some derivatives with a short chain at the C-4 position displayed selective antimicrobial activity against Candida albicans and they showed MIC values similar to those displayed by trichodermin. It is important to highlight the cytotoxic selectivity observed for compounds 9, 13, and 15, which presented average IC50 values of 2 µg/mL and were cytotoxic against tumorigenic cell line MCF-7 (breast carcinoma) and not against Fa2N4 (non-tumoral immortalized human hepatocytes)
108. Lobophorin K, a New Natural Product with Cytotoxic Activity Produced by Streptomyces sp. M-207 Associated with the Deep-Sea Coral Lophelia pertusa
- Author
-
Miguel Osset, Nuria de Pedro, Ignacio Pérez-Victoria, Luis A. García, Caridad Díaz, Mercedes de la Cruz, Jesús Martín, Alfredo F. Braña, Fernando Reyes, Francisca Vicente, Gloria Blanco, Aida Sarmiento-Vizcaíno, [Brana, Alfredo F.] Univ Oviedo, Inst Univ Oncol Principado Asturias, Area Microbiol, Dept Biol, E-33006 Oviedo, Spain, [Sarmiento-Vizcaino, Aida] Univ Oviedo, Inst Univ Oncol Principado Asturias, Area Microbiol, Dept Biol, E-33006 Oviedo, Spain, [Osset, Miguel] Univ Oviedo, Inst Univ Oncol Principado Asturias, Area Microbiol, Dept Biol, E-33006 Oviedo, Spain, [Blanco, Gloria] Univ Oviedo, Inst Univ Oncol Principado Asturias, Area Microbiol, Dept Biol, E-33006 Oviedo, Spain, [Perez-Victoria, Ignacio] Ctr Excelencia Invest Med Innovadores Andalucia, Fdn MEDINA, Avda Conocimiento 3,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain, [Martin, Jesus] Ctr Excelencia Invest Med Innovadores Andalucia, Fdn MEDINA, Avda Conocimiento 3,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain, [de Pedro, Nuria] Ctr Excelencia Invest Med Innovadores Andalucia, Fdn MEDINA, Avda Conocimiento 3,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain, [de la Cruz, Mercedes] Ctr Excelencia Invest Med Innovadores Andalucia, Fdn MEDINA, Avda Conocimiento 3,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain, [Diaz, Caridad] Ctr Excelencia Invest Med Innovadores Andalucia, Fdn MEDINA, Avda Conocimiento 3,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain, [Vicente, Francisca] Ctr Excelencia Invest Med Innovadores Andalucia, Fdn MEDINA, Avda Conocimiento 3,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain, [Reyes, Fernando] Ctr Excelencia Invest Med Innovadores Andalucia, Fdn MEDINA, Avda Conocimiento 3,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain, [Garcia, Luis A.] Univ Oviedo, Area Ingn Quim, Dept Ingn Quim & Tecnol Medio Ambiente, Oviedo 33006, Spain, Universidad de Oviedo, Gobierno del Principado de Asturias, and Ministerio de Ciencia e Innovacion
- Subjects
0301 basic medicine ,Cell Survival ,Coral ,Pharmaceutical Science ,Antineoplastic Agents ,Microbial Sensitivity Tests ,medicine.disease_cause ,01 natural sciences ,Deep sea ,Streptomyces ,Article ,Microbiology ,Actinobacteria ,03 medical and health sciences ,chemistry.chemical_compound ,Lophelia ,lobophorins ,spirotetronate antibiotic ,antitumor ,Cantabrian Sea-derived actinobacteria ,Cell Line, Tumor ,Drug Discovery ,Botany ,Metabolites ,medicine ,Animals ,Humans ,Pharmacology, Toxicology and Pharmaceutics (miscellaneous) ,Phylogeny ,Natural product ,Molecular Structure ,biology ,Anthozoa ,biology.organism_classification ,0104 chemical sciences ,010404 medicinal & biomolecular chemistry ,030104 developmental biology ,chemistry ,Staphylococcus aureus ,Spirotetronate antibiotics ,Macrolides ,Bacteria - Abstract
The present article describes the isolation of a new natural product of the lobophorin family, designated as lobophorin K (1), from cultures of the marine actinobacteria Streptomyces sp. M-207, previously isolated from the cold-water coral Lophelia pertusa collected at 1800 m depth during an expedition to the submarine Avilés Canyon. Its structure was determined using a combination of spectroscopic techniques, mainly ESI-TOF MS and 1D and 2D NMR. This new natural product displayed cytotoxic activity against two human tumor cell lines, such as pancreatic carcinoma (MiaPaca-2) and breast adenocarcinoma (MCF-7). Lobophorin K also displayed moderate and selective antibiotic activity against pathogenic Gram-positive bacteria such as Staphylococcus aureus., The authors are grateful to José Luis Acuña for his invitation to the BIOCANT3 oceanographic expedition (DOSMARES) where Streptomyces sp. M-207 was isolated. This study was financially supported by the Universidad de Oviedo (UNOV-11-MA-02) and Gobierno del Principado de Asturias (SV-PA-13-ECOEMP-62). The polarimeter, IR, and NMR equipment used in this work were acquired via grants for scientific and technological infrastructures from the Ministerio de Ciencia e Innovación (Grants No. PCT-010000-2010-4 (NMR), INP-2011-0016-PCT-010000 ACT6 (polarimeter and IR)). This is a contribution of the Asturias Marine Observatory.
- Published
- 2017
- Full Text
- View/download PDF
109. Paulomycin G, a new natural product with cytotoxic activity against tumor cell lines produced by deep-sea sediment derived Micromonospora matsumotoense M-412 from the Avilés Canyon in the Cantabrian Sea
- Author
-
Ignacio Pérez-Victoria, Luis A. García, Nuria de Pedro, Alfredo F. Braña, Jesús Martín, Gloria Blanco, Caridad Díaz, Francisca Vicente, José Luis Acuña, Mercedes de la Cruz, Fernando Reyes, Aida Sarmiento-Vizcaíno, [Sarmiento-Vizcaino, Aida] Univ Oviedo, Dept Biol Func, Area Microbiol, E-33006 Oviedo, Spain, [Brana, Alfredo F.] Univ Oviedo, Dept Biol Func, Area Microbiol, E-33006 Oviedo, Spain, [Blanco, Gloria] Univ Oviedo, Dept Biol Func, Area Microbiol, E-33006 Oviedo, Spain, [Sarmiento-Vizcaino, Aida] Univ Oviedo, Inst Univ Oncol Principado Asturias, E-33006 Oviedo, Spain, [Brana, Alfredo F.] Univ Oviedo, Inst Univ Oncol Principado Asturias, E-33006 Oviedo, Spain, [Blanco, Gloria] Univ Oviedo, Inst Univ Oncol Principado Asturias, E-33006 Oviedo, Spain, [Perez-Victoria, Ignacio] Fdn MEDINA, Ctr Excelencia Invest Medicamentos Innovadores An, Avda Conocimiento 34,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain, [Martin, Jesus] Fdn MEDINA, Ctr Excelencia Invest Medicamentos Innovadores An, Avda Conocimiento 34,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain, [de Pedro, Nuria] Fdn MEDINA, Ctr Excelencia Invest Medicamentos Innovadores An, Avda Conocimiento 34,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain, [de la Cruz, Mercedes] Fdn MEDINA, Ctr Excelencia Invest Medicamentos Innovadores An, Avda Conocimiento 34,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain, [Diaz, Caridad] Fdn MEDINA, Ctr Excelencia Invest Medicamentos Innovadores An, Avda Conocimiento 34,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain, [Vicente, Francisca] Fdn MEDINA, Ctr Excelencia Invest Medicamentos Innovadores An, Avda Conocimiento 34,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain, [Reyes, Fernando] Fdn MEDINA, Ctr Excelencia Invest Medicamentos Innovadores An, Avda Conocimiento 34,Parque Tecnol Ciencias Salud, E-18016 Granada, Spain, [Acuna, Jose L.] Univ Oviedo, Area Ecol, Dept Biol Organismos & Sistemas, E-33006 Oviedo, Spain, [Garcia, Luis A.] Univ Oviedo, Area Ingn Quim, Dept Ingn Quim & Tecnol Medio Ambiente, E-33006 Oviedo, Spain, Gobierno del Principado de Asturias, and Ministerio de Ciencia e Innovacion
- Subjects
0301 basic medicine ,Geologic Sediments ,Pharmaceutical Science ,Disaccharides ,Micromonospora ,chemistry.chemical_compound ,Drug Discovery ,Cytotoxic T cell ,paulomycins ,Pharmacology, Toxicology and Pharmaceutics (miscellaneous) ,lcsh:QH301-705.5 ,Phylogeny ,antitumor ,Canyon ,geography.geographical_feature_category ,Molecular Structure ,Liver Neoplasms ,Streptomyces-albus ,Hep G2 Cells ,Streptomyces ,Anti-Bacterial Agents ,MCF-7 Cells ,Strategies ,Carcinoma, Hepatocellular ,Micromonospora matsumotoense ,Oceans and Seas ,030106 microbiology ,Tumor cells ,Antineoplastic Agents ,Marine Biology ,Biology ,Deep sea ,Article ,03 medical and health sciences ,Sponge ,Cell Line, Tumor ,Botany ,Cyclohexenes ,Humans ,Cantabrian Sea-derived actinobacteria ,Nuclear Magnetic Resonance, Biomolecular ,geography ,Natural product ,Dose-Response Relationship, Drug ,Sediment ,Antitumor ,biology.organism_classification ,Molecular biology ,030104 developmental biology ,chemistry ,lcsh:Biology (General) ,Drug Screening Assays, Antitumor - Abstract
The present article describes a structurally novel natural product of the paulomycin family, designated as paulomycin G (1), obtained from the marine strain Micromonospora matsumotoense M-412, isolated from Cantabrian Sea sediments collected at 2000 m depth during an oceanographic expedition to the submarine Aviles Canyon. Paulomycin G is structurally unique since—to our knowledge—it is the first member of the paulomycin family of antibiotics lacking the paulomycose moiety. It is also the smallest bioactive paulomycin reported. Its structure was determined using HRMS and 1D and 2D NMR spectroscopy. This novel natural product displays strong cytotoxic activities against different human tumour cell lines, such as pancreatic adenocarcinoma (MiaPaca_2), breast adenocarcinoma (MCF-7), and hepatocellular carcinoma (HepG2). The compound did not show any significant bioactivity when tested against a panel of bacterial and fungal pathogens.
- Published
- 2017
110. Discovery of a Novel, Isothiazolonaphthoquinone-Based Small Molecule Activator of FOXO Nuclear-Cytoplasmic Shuttling
- Author
-
Francisco Castillo, Susana Machado, Lorena Rodriguez Quesada, Francisca Vicente, Sabrina Dallavalle, Nuria de Pedro, Bastien Cautain, Wolfgang Link, Bibiana I. Ferreira, Loana Musso, [Cautain, Bastien] Fdn MEDINA, Parque Tecnol Ciencias Salud, Granada, Spain, [Castillo, Francisco] Fdn MEDINA, Parque Tecnol Ciencias Salud, Granada, Spain, [de Pedro, Nuria] Fdn MEDINA, Parque Tecnol Ciencias Salud, Granada, Spain, [Quesada, Lorena Rodriguez] Fdn MEDINA, Parque Tecnol Ciencias Salud, Granada, Spain, [Vicente, Francisca] Fdn MEDINA, Parque Tecnol Ciencias Salud, Granada, Spain, [Musso, Loana] Univ Milan, DeFENS Dept Food Environm & Nutr Sci, I-20122 Milan, Italy, [Dallavalle, Sabrina] Univ Milan, DeFENS Dept Food Environm & Nutr Sci, I-20122 Milan, Italy, [Ferreira, Bibiana I.] Ctr Biomed Res CBMR, Gambelas Campus, Faro, Portugal, [Machado, Susana] Ctr Biomed Res CBMR, Gambelas Campus, Faro, Portugal, [Link, Wolfgang] Ctr Biomed Res CBMR, Gambelas Campus, Faro, Portugal, [Ferreira, Bibiana I.] Univ Algarve, Dept Biomed Sci & Med, Regenerat Med Program, Campus Gambelas, Faro, Portugal, [Link, Wolfgang] Univ Algarve, Dept Biomed Sci & Med, Regenerat Med Program, Campus Gambelas, Faro, Portugal, Fundacao para a Ciencia e a Tecnologia (FCT) Research Center, FCT, and ProRegem grant
- Subjects
0301 basic medicine ,Cytoplasm ,Cancer Treatment ,Gene Expression ,lcsh:Medicine ,Biochemistry ,Medicine and Health Sciences ,lcsh:Science ,Cancer ,Staining ,Microscopy, Confocal ,Multidisciplinary ,Molecular Structure ,Forkhead Box Protein O1 ,Forkhead Box Protein O3 ,Hep G2 Cells ,Specimen preparation and treatment ,Small molecule ,3. Good health ,Transport protein ,Cell biology ,Subcellular Localization ,Chemistry ,Protein Transport ,medicine.anatomical_structure ,Oncology ,High-content screening ,Physical Sciences ,MCF-7 Cells ,Cellular Structures and Organelles ,Research Article ,Cell Survival ,Cells ,DNA transcription ,Translocation ,Biology ,Green Fluorescent Protein ,Cell Line ,Small Molecule Libraries ,03 medical and health sciences ,Forkhead Box ,Protein Domains ,Chlorides ,Cell Line, Tumor ,DNA-binding proteins ,Genetics ,medicine ,Humans ,Gene Regulation ,Nuclear export signal ,Transcription factor ,Forkhead transcription factor ,Cell Nucleus ,Biology and life sciences ,Dose-Response Relationship, Drug ,Inhibitors ,Activator (genetics) ,lcsh:R ,Dual-specificity phosphatase ,DAPI staining ,Chemical Compounds ,Proteins ,Cycloaddition reactions ,Cell Biology ,Subcellular localization ,Molecular biology ,Regulatory Proteins ,Research and analysis methods ,Luminescent Proteins ,Thiazoles ,Cell nucleus ,Potent ,030104 developmental biology ,Models, Chemical ,Screen ,Nuclear staining ,lcsh:Q ,Nitrile sulfides ,Transcription Factors ,Naphthoquinones - Abstract
FOXO factors are tumour suppressor proteins commonly inactivated in human tumours by posttranslational modifications. Furthermore, genetic variation within the FOXO3a gene is consistently associated with human longevity. Therefore, the pharmacological activation of FOXO proteins is considered as an attractive therapeutic approach to treat cancer and age-related diseases. In order to identify agents capable of activating FOXOs, we tested a collection of small chemical compounds using image-based high content screening technology. Here, we report the discovery of LOM612 (compound 1a), a newly synthesized isothiazolonaphthoquinone as a potent FOXO relocator. Compound 1a induces nuclear translocation of a FOXO3a reporter protein as well as endogenous FOXO3a and FOXO1 in U2OS cells in a dose-dependent manner. This activity does not affect the subcellular localization of other cellular proteins including NFkB or inhibit CRM1-mediated nuclear export. Furthermore, compound 1a shows a potent antiproliferative effect in human cancer cell lines.
- Published
- 2016
111. Telomere-based risk models for the early diagnosis of lung cancer.
- Author
-
Molina-Pinelo S, Ferrer Sánchez I, Najarro P, Paz-Ares L, Fernández L, Castelló N, Richart López LA, Rodríguez Gambarte JD, Sanz García M, Salinas A, Suárez R, Romero-Romero B, Martín-Juan J, Viñuela ME, Butler RG, and de Pedro N
- Abstract
Background: The objective of this study was to evaluate the use of telomere length measurements as diagnostic biomarkers during early screening for lung cancer in high-risk patients., Methods: This was a prospective study of patients undergoing lung cancer diagnosis at two Spanish hospitals between April 2017 and January 2020. Telomeres from peripheral blood lymphocytes were analysed by Telomere Analysis Technology, which is based in high-throughput quantitative fluorescent in situ hybridization. Analytical predictive models were developed using Random Forest from the dataset of telomere-associated variables (TAV). Receiver Operating Characteristic curves were used to characterize model performance., Findings: From 233 patients undergoing lung cancer diagnosis, 106 patients aged 55-75 with lung cancer or lung cancer and COPD were selected. A control group (N = 453) included individuals of similar age with COPD or healthy. Telomere analysis showed that patients in the cancer cohort had a higher proportion of short telomeres compared to the control cohort. A TAV-based predictive model assuming a prevalence of 5 % of lung cancer among screened subjects showed an AUC of 0.98 %, a positive predictive value of 0.60 (95 % CI, 0.49-0.70) and a negative predictive value of 0.99 (95 % CI, 0.98-0.99) for prediction of lung cancer., Interpretation: The results of this study suggest that TAV analysis in peripheral lymphocytes can be considered a useful diagnostic tool during screening for lung cancer in high-risk patients. TAV-based models could improve the predictive power of current initial diagnostic pathways, but further work is needed to integrate them into routine clinical evaluation., Funding: Life Length SL., Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Life Length SL reports financial support was provided by European Commission. Sonia Molina-Pinelo reports financial support was provided by Life Length S. Luis Paz-Ares reports financial support was provided by 10.13039/100012818Community of Madrid. Luis Paz-Ares reports financial support was provided by Asociación Española contra el Cáncer. Sonia Molina-Pinelo reports financial support was provided by Andalusian Research, Development and Innovation Plan. Sonia Molina-Pinelo reports financial support was provided by European Regional Development Fund. Luis Paz-Ares reports financial support was provided by European Regional Development Fund. Sonia Molina-Pinelo reports financial support was provided by 10.13039/501100004587Carlos III Health Institute. Luis Paz-Ares reports financial support was provided by 10.13039/501100004587Carlos III Health Institute. Luis Paz-Ares reports was provided by Fundación CRIS contra el cancer. Luis Paz-Ares reports financial support was provided by Biomedical Research Network Centre in Cancer. Irene Ferrer Sanchez reports financial support was provided by 10.13039/501100004587Carlos III Health Institute. Irene Ferrer Sanchez reports financial support was provided by European Regional Development Fund. PN, LF, NC, and NdP are or have been employees and/or investors of Life Length SL. LP-A has received honoraria for scientific advice and speaker fees from Lilly, Merck Sharp & Dohme, Bristol-Myers Squibb, Roche, PharmaMar, Merck, AstraZeneca, Novartis, Boehringer Ingelheim, Celgene, Servier, Sysmex, Amgen, Incyte, Pfizer, Ipsen, Adacap, Sanofi, Bayer and Blueprint, and participates as an external member on the board of Genómica. He is founder and board member of Altum sequencing and has received institutional support for contracted research from Merck Sharp & Dohme, Bristol-Myers Squibb, AstraZeneca and Pfizer. Other authors declare no potential conflicts of interest., (© 2024 The Authors. Published by Elsevier Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
112. Is there direct photoentrainment in the goldfish liver? Wavelength-dependent regulation of clock genes and investigation of the opsin 7 family.
- Author
-
Saiz N, Alonso-Gómez ÁL, Bustamante-Martínez S, de Pedro N, Delgado MJ, and Isorna E
- Abstract
Widespread direct photoentrainment in zebrafish peripheral tissues is linked to diverse non-visual opsins. To explore whether this broadly distributed photosensitivity is specific to zebrafish or is a general teleost feature, we investigated hepatic photosynchronization in goldfish. First, we focused on the opsin 7 family (OPN7, a key peripheral novel opsin in zebrafish), investigating its presence in the goldfish liver. Subsequently, we studied whether light can directly entrain the goldfish liver and retina clocks. Silico analysis revealed seven OPN7 paralogs from four gene families, suggesting expansion through whole-genome and tandem duplications. The paralogs of families OPN7a, OPN7b, and OPN7d were mainly localized in neural tissues, while OPN7c paralogs were more abundant in peripheral tissues-including the liver-suggesting divergent roles. Light (independently of the wavelength employed) directly induced the per2a clock gene in the retina both in vivo and in vitro, confirming expected photoentrainment. However, in the liver, photoinduction of per1a and cry1a only occurred in vivo, not in vitro. These results suggest an indirect light-entrainment mechanism of the goldfish hepatic clock, possibly mediated by other oscillators or photosensitive organs. Our findings challenge the assumption of widespread direct photosensitivity in the peripheral tissues of teleosts. Further research is needed to understand the role of tissue-specific photoentrainment and non-visual opsins in diverse teleost species., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
113. Onychocolone A produced by the fungus Onychocola sp. targets cancer stem cells and stops pancreatic cancer progression by inhibiting MEK2-dependent cell signaling.
- Author
-
Ramos MC, Crespo-Sueiro G, de Pedro N, Griñán-Lisón C, Díaz C, Pérez-Victoria I, González-Menéndez V, Castillo F, Pérez Del Palacio J, Tormo JR, Choquesillo-Lazarte D, Marchal JA, Vicente F, Fernández-Godino R, Genilloud O, and Reyes F
- Subjects
- Animals, Humans, Cell Line, Tumor, Mice, Benzophenones pharmacology, Benzophenones chemistry, Xenograft Model Antitumor Assays, Ascomycota chemistry, Mice, Nude, Cell Proliferation drug effects, Pancreatic Neoplasms drug therapy, Pancreatic Neoplasms pathology, Neoplastic Stem Cells drug effects, Neoplastic Stem Cells pathology, Neoplastic Stem Cells metabolism, Signal Transduction drug effects, Antineoplastic Agents pharmacology
- Abstract
Pancreatic cancer (PC) shows a high fatality rate that can only be faced with a combination of surgery and chemotherapy or palliative treatment in the case of advanced patients. Besides, PC tumors are enriched with subpopulations of cancer stem cells (CSCs) that are resistant to the existing chemotherapeutic agents, which raises an important need for the identification of new drugs. To fill this gap, we have tested the anti-tumoral activity of microbial extracts, which chemical diversity offers a broad spectrum of potential new bioactive compounds. Extracts derived from the fungus Onychocola sp. CF-107644 were assayed via high throughput screening followed by bioassay-guided fractionation and resulted in the identification and isolation of six benzophenone derivatives with antitumoral activity: onychocolones A-F (#1-6). The structures of the compounds were established by spectroscopic methods, including ESI-TOF MS, 1D and 2D NMR analyses and X-ray diffraction. Compounds #1-4 significantly inhibited the growth of the pancreas tumoral cell lines, with low-micromolar Median Effective Doses (ED
50 s). Compound #1 (onychocolone A) was prioritized for further profiling due to its pro-apoptotic effect, which was further validated on 3D spheroids and pancreatic CSCs. Protein expression assays showed that the effect was mechanistically linked to the inhibition of MEK onco-signaling pathway. The efficacy of onychocolone A was also demonstrated in vivo by the reduction of tumor growth in a pancreatic xenograft mouse model generated by CSCs. Altogether, the data support that onychocolone A is a promising new small molecule for hit-to-lead development of a new treatment for PC., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
114. Distinct intestinal microbial signatures linked to accelerated systemic and intestinal biological aging.
- Author
-
Singh S, Giron LB, Shaikh MW, Shankaran S, Engen PA, Bogin ZR, Bambi SA, Goldman AR, Azevedo JLLC, Orgaz L, de Pedro N, González P, Giera M, Verhoeven A, Sánchez-López E, Pandrea I, Kannan T, Tanes CE, Bittinger K, Landay AL, Corley MJ, Keshavarzian A, and Abdel-Mohsen M
- Subjects
- Humans, Female, Male, Dysbiosis microbiology, Intestines microbiology, Aging, Bacteria genetics, Inflammation microbiology, Anti-Inflammatory Agents, HIV Infections drug therapy, Gastrointestinal Microbiome genetics
- Abstract
Background: People living with HIV (PLWH), even when viral replication is controlled through antiretroviral therapy (ART), experience persistent inflammation. This inflammation is partly attributed to intestinal microbial dysbiosis and translocation, which may lead to non-AIDS-related aging-associated comorbidities. The extent to which living with HIV - influenced by the infection itself, ART usage, sexual orientation, or other associated factors - affects the biological age of the intestines is unclear. Furthermore, the role of microbial dysbiosis and translocation in the biological aging of PLWH remains to be elucidated. To investigate these uncertainties, we used a systems biology approach, analyzing colon and ileal biopsies, blood samples, and stool specimens from PLWH on ART and people living without HIV (PLWoH) as controls., Results: PLWH exhibit accelerated biological aging in the colon, ileum, and blood, as measured by various epigenetic aging clocks, compared to PLWoH. Investigating the relationship between microbial translocation and biological aging, PLWH had decreased levels of tight junction proteins in the intestines, along with increased microbial translocation. This intestinal permeability correlated with faster biological aging and increased inflammation. When investigating the relationship between microbial dysbiosis and biological aging, the intestines of PLWH had higher abundance of specific pro-inflammatory bacteria, such as Catenibacterium and Prevotella. These bacteria correlated with accelerated biological aging. Conversely, the intestines of PLWH had lower abundance of bacteria known for producing the anti-inflammatory short-chain fatty acids, such as Subdoligranulum and Erysipelotrichaceae, and these bacteria were associated with slower biological aging. Correlation networks revealed significant links between specific microbial genera in the colon and ileum (but not in feces), increased aging, a rise in pro-inflammatory microbe-related metabolites (e.g., those in the tryptophan metabolism pathway), and a decrease in anti-inflammatory metabolites like hippuric acid., Conclusions: We identified specific microbial compositions and microbiota-related metabolic pathways that are intertwined with intestinal and systemic biological aging. This microbial signature of biological aging is likely reflecting various factors including the HIV infection itself, ART usage, sexual orientation, and other aspects associated with living with HIV. A deeper understanding of the mechanisms underlying these connections could offer potential strategies to mitigate accelerated aging and its associated health complications. Video Abstract., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
115. Distinct Intestinal Microbial Signatures Linked to Accelerated Biological Aging in People with HIV.
- Author
-
Singh S, Giron LB, Shaikh MW, Shankaran S, Engen PA, Bogin ZR, Bambi SA, Goldman AR, Azevedo JLLC, Orgaz L, de Pedro N, González P, Giera M, Verhoeven A, Sánchez-López E, Pandrea IV, Kannan T, Tanes CE, Bittinger K, Landay AL, Corley MJ, Keshavarzian A, and Abdel-Mohsen M
- Abstract
Background: People with HIV (PWH), even with controlled viral replication through antiretroviral therapy (ART), experience persistent inflammation. This is partly due to intestinal microbial dysbiosis and translocation. Such ongoing inflammation may lead to the development of non-AIDS-related aging-associated comorbidities. However, there remains uncertainty regarding whether HIV affects the biological age of the intestines and whether microbial dysbiosis and translocation influence the biological aging process in PWH on ART. To fill this knowledge gap, we utilized a systems biology approach, analyzing colon and ileal biopsies, blood samples, and stool specimens from PWH on ART and their matched HIV-negative counterparts., Results: Despite having similar chronological ages, PWH on ART exhibit accelerated biological aging in the colon, ileum, and blood, as measured by various epigenetic aging clocks, compared to HIV-negative controls. Investigating the relationship between microbial translocation and biological aging, PWH on ART had decreased levels of tight junction proteins in the colon and ileum, along with increased microbial translocation. This increased intestinal permeability correlated with faster intestinal and systemic biological aging, as well as increased systemic inflammation. When investigating the relationship between microbial dysbiosis and biological aging, the intestines of PWH on ART had higher abundance of specific pro-inflammatory bacterial genera, such as Catenibacterium and Prevotella . These bacteria significantly correlated with accelerated local and systemic biological aging. Conversely, the intestines of PWH on ART had lower abundance of bacterial genera known for producing short-chain fatty acids and exhibiting anti-inflammatory properties, such as Subdoligranulum and Erysipelotrichaceae , and these bacteria taxa were associated with slower biological aging. Correlation networks revealed significant links between specific microbial genera in the colon and ileum (but not in feces), increased aging, a rise in pro-inflammatory microbial-related metabolites (e.g., those in the tryptophan metabolism pathway), and a decrease in anti-inflammatory metabolites like hippuric acid and oleic acid., Conclusions: We identified a specific microbial composition and microbiome-related metabolic pathways that are intertwined with both intestinal and systemic biological aging in PWH on ART. A deeper understanding of the mechanisms underlying these connections could potentially offer strategies to counteract premature aging and its associated health complications in PWH., Competing Interests: Competing interests The authors have no competing interests.
- Published
- 2023
- Full Text
- View/download PDF
116. Daily rhythms of REV-ERBα and its role as transcriptional repressor of clock genes in fish hepatic oscillator.
- Author
-
Saiz N, Herrera-Castillo L, Gómez-Boronat M, Delgado MJ, Isorna E, and de Pedro N
- Subjects
- Animals, Thiophenes metabolism, Liver metabolism, Mammals metabolism, Circadian Rhythm genetics, Transcription Factors metabolism
- Abstract
The REV-ERBα nuclear receptor is a key component of the molecular machinery of circadian oscillators in mammals. While the rhythmic expression of this receptor has been described in teleosts, several critical aspects of its regulation remain unknown, such as which synchronizers entrain its rhythm, and whether it can modulate the expression of other clock genes. The objective of this study was to gain deeper understanding of the role of REV-ERBα in the fish circadian system. To this end, we first investigated the cues that entrain the rhythm of rev-erbα expression in the goldfish (Carassius auratus) liver and hypothalamus. A 12-h shift in feeding time induced a parallel shift in the hepatic rhythm of rev-erbα expression, confirming that this gene is food-entrainable in the goldfish liver. In contrast, light seems the main driver of rev-erbα rhythmic expression in the hypothalamus. Next, we examined the effects of REV-ERBα activation on locomotor activity and hepatic expression of clock genes. Subchronic treatment with the REV-ERBα agonist SR9009 slightly decreased locomotor activity anticipating light onset and food arrival, and downregulated hepatic bmal1a, clock1a, cry1a, per1a and pparα expression. This generalized repressing action of REV-ERBα on the expression of hepatic clock genes was confirmed in vitro by using agonists (SR9009 and GSK4112) and antagonist (SR8278) of this receptor. Overall, the present work reveals that REV-ERBα modulates the daily expression of the main genes of the teleostean liver clock, reinforcing its role in the liver temporal homeostasis, which seems highly conserved in both fish and mammals., Competing Interests: Declaration of competing interest The authors declare not conflicts of interest., (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
117. Engineering osteoarthritic cartilage model through differentiating senescent human mesenchymal stem cells for testing disease-modifying drugs.
- Author
-
Wang N, He Y, Liu S, Makarcyzk MJ, Lei G, Chang A, Alexander PG, Hao T, Padget AM, de Pedro N, Menelaos T, and Lin H
- Subjects
- Antirheumatic Agents therapeutic use, Cartilage metabolism, Cartilage pathology, Cell Differentiation, Cells, Cultured, Cellular Senescence genetics, Chondrocytes drug effects, Chondrocytes metabolism, Chondrocytes pathology, Drug Evaluation, Preclinical, Humans, Mesenchymal Stem Cells metabolism, Osteoarthritis metabolism, Osteoarthritis pathology, Senotherapeutics pharmacology, Tissue Engineering, Transcriptome, Antirheumatic Agents pharmacology, Cartilage drug effects, Cellular Senescence drug effects, Mesenchymal Stem Cells cytology, Models, Biological, Osteoarthritis drug therapy
- Abstract
Significant cellular senescence has been observed in cartilage harvested from patients with osteoarthritis (OA). In this study, we aim to develop a senescence-relevant OA-like cartilage model for developing disease-modifying OA drugs (DMOADs). Specifically, human bone marrow-derived mesenchymal stromal cells (MSCs) were expanded in vitro up to passage 10 (P10-MSCs). Following their senescent phenotype formation, P10-MSCs were subjected to pellet culture in chondrogenic medium. Results from qRT-PCR, histology, and immunostaining indicated that cartilage generated from P10-MSCs displayed both senescent and OA-like phenotypes without using other OA-inducing agents, when compared to that from normal passage 4 (P4)-MSCs. Interestingly, the same gene expression differences observed between P4-MSCs and P10-MSC-derived cartilage tissues were also observed between the preserved and damaged OA cartilage regions taken from human samples, as demonstrated by RNA Sequencing data and other analysis methods. Lastly, the utility of this senescence-initiated OA-like cartilage model in drug development was assessed by testing several potential DMOADs and senolytics. The results suggest that pre-existing cellular senescence can induce the generation of OA-like changes in cartilage. The P4- and P10-MSCs derived cartilage models also represent a novel platform for predicting the efficacy and toxicity of potential DMOADs on both preserved and damaged cartilage in humans., (© 2022. Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
118. Diurnal Profiles of N -Acylethanolamines in Goldfish Brain and Gastrointestinal Tract: Possible Role of Feeding.
- Author
-
Gómez-Boronat M, Isorna E, Armirotti A, Delgado MJ, Piomelli D, and de Pedro N
- Abstract
N -acylethanolamines (NAEs) are a family of endogenous lipid signaling molecules that are involved in regulation of energy homeostasis in vertebrates with a putative role on circadian system. The aim of this work was to study the existence of daily fluctuations in components of NAEs system and their possible dependence on food intake. Specifically, we analyzed the content of oleoylethanolamide (OEA), palmitoylethanolamide (PEA), stearoylethanolamide (SEA), their precursors (NAPEs), as well as the expression of nape-pld (NAEs synthesis enzyme), faah (NAEs degradation enzyme), and pparα (NAEs receptor) in gastrointestinal and brain tissues of goldfish ( Carassius auratus ) throughout a 24-h cycle. Daily profiles of bmal1a and rev -erbα expression in gastrointestinal tissues were also quantified because these clock genes are also involved in lipid metabolism, are PPAR-targets in mammals, and could be a link between NAEs and circadian system in fish. Gastrointestinal levels of NAEs exhibited daily fluctuations, with a pronounced and rapid postprandial increase, the increment being likely caused by food intake as it is not present in fasted animals. Such periprandial differences were not found in brain, supporting that NAEs mobilization occurs in a tissue-specific manner and suggesting that these three NAEs could be acting as peripheral satiety signals. The abundance of pparα mRNA displayed a daily rhythm in the intestine and the liver, suggesting a possible rhythmicity in the NAEs functionality. The increment of pparα expression during the rest phase can be related with its role stimulating lipid catabolism to obtain energy during the fasting state of the animals. In addition, the clock genes bmal1a and rev -erbα also showed daily rhythms, with a bmal1a increment after feeding, supporting its role as a lipogenic factor. In summary, our data show the existence of all components of NAEs system in fish (OEA, PEA, SEA, precursors, synthesis and degradation enzymes, and the receptor PPARα), supporting the involvement of NAEs as peripheral satiety signals.
- Published
- 2019
- Full Text
- View/download PDF
119. Chemical Genomics-Based Antifungal Drug Discovery: Targeting Glycosylphosphatidylinositol (GPI) Precursor Biosynthesis.
- Author
-
Mann PA, McLellan CA, Koseoglu S, Si Q, Kuzmin E, Flattery A, Harris G, Sher X, Murgolo N, Wang H, Devito K, de Pedro N, Genilloud O, Kahn JN, Jiang B, Costanzo M, Boone C, Garlisi CG, Lindquist S, and Roemer T
- Abstract
Steadily increasing antifungal drug resistance and persistent high rates of fungal-associated mortality highlight the dire need for the development of novel antifungals. Characterization of inhibitors of one enzyme in the GPI anchor pathway, Gwt1, has generated interest in the exploration of targets in this pathway for further study. Utilizing a chemical genomics-based screening platform referred to as the Candida albicans fitness test (CaFT), we have identified novel inhibitors of Gwt1 and a second enzyme in the glycosylphosphatidylinositol (GPI) cell wall anchor pathway, Mcd4. We further validate these targets using the model fungal organism Saccharomyces cerevisiae and demonstrate the utility of using the facile toolbox that has been compiled in this species to further explore target specific biology. Using these compounds as probes, we demonstrate that inhibition of Mcd4 as well as Gwt1 blocks the growth of a broad spectrum of fungal pathogens and exposes key elicitors of pathogen recognition. Interestingly, a strong chemical synergy is also observed by combining Gwt1 and Mcd4 inhibitors, mirroring the demonstrated synthetic lethality of combining conditional mutants of GWT1 and MCD4. We further demonstrate that the Mcd4 inhibitor M720 is efficacious in a murine infection model of systemic candidiasis. Our results establish Mcd4 as a promising antifungal target and confirm the GPI cell wall anchor synthesis pathway as a promising antifungal target area by demonstrating that effects of inhibiting it are more general than previously recognized.
- Published
- 2015
- Full Text
- View/download PDF
120. Image-based identification of nuclear export inhibitors from natural products.
- Author
-
Cautain B, de Pedro N, Reyes F, and Link W
- Subjects
- Cell Line, Cytoplasm metabolism, Dose-Response Relationship, Drug, High-Throughput Screening Assays, Humans, Protein Transport drug effects, Active Transport, Cell Nucleus drug effects, Biological Products pharmacology, Drug Evaluation, Preclinical methods, Microscopy, Confocal methods, Proteins metabolism
- Abstract
High-content imaging with robotic microscopy has been widely used for phenotype-based cellular screening research. This technology is ideally suited to monitor intracellular translocation of macromolecules. Here, we describe in detail the procedures for screening microbial natural extracts for their capability to inhibit the general nuclear export machinery. The method is based on human cells that stably express a fluorescent-tagged reporter protein that contain a nuclear export signal capable of mediating its translocation from the nucleus to the cytoplasm through the nuclear pore. In the presence of a small molecule nuclear export inhibitor, the fluorescent signal is trapped to varying degrees within the nucleus. In order to analyze complex libraries of compounds, the assay has been scaled to 96- or 384-well formats and optimized for high-throughput screening (HTS). Active microbial extracts undergo confirmation screening, bioassay-guided fractionation, chemical dereplication, and compound purification. The active purified compound is characterized in secondary assays that monitor the nuclear export of disease-relevant proteins. Nuclear export inhibitors hold promise as potential cancer and antiviral drugs.
- Published
- 2015
- Full Text
- View/download PDF
121. Targeting nucleocytoplasmic transport in cancer therapy.
- Author
-
Hill R, Cautain B, de Pedro N, and Link W
- Subjects
- Active Transport, Cell Nucleus physiology, Animals, Humans, Signal Transduction, Neoplasms metabolism, Neoplasms therapy
- Abstract
The intracellular location and regulation of proteins within each cell is critically important and is typically deregulated in disease especially cancer. The clinical hypothesis for inhibiting the nucleo-cytoplasmic transport is based on the dependence of certain key proteins within malignant cells. This includes a host of well-characterized tumor suppressor and oncoproteins that require specific localization for their function. This aberrant localization of tumour suppressors and oncoproteins results in their their respective inactivation or over-activation. This incorrect localization occurs actively via the nuclear pore complex that spans the nuclear envelope and is mediated by transport receptors. Accordingly, given the significant need for novel, specific disease treatments, the nuclear envelope and the nuclear transport machinery have emerged as a rational therapeutic target in oncology to restore physiological nucleus/cytoplasmic homeostasis. Recent evidence suggests that this approach might be of substantial therapeutic use. This review summarizes the mechanisms of nucleo-cytoplasmic transport, its role in cancer biology and the therapeutic potential of targeting this critical cellular process.
- Published
- 2014
- Full Text
- View/download PDF
122. Effects of 14-methoxymetopon, a potent opioid agonist, on the responses to the tail electric stimulation test and plus-maze activity in male rats: neuroendocrine correlates.
- Author
-
Urigüen L, Fernández B, Romero EM, De Pedro N, Delgado MJ, Guaza C, Schmidhammer H, and Viveros MP
- Subjects
- Animals, Anxiety metabolism, Anxiety physiopathology, Brain metabolism, Corticosterone blood, Corticosterone metabolism, Electric Stimulation, Hypothalamo-Hypophyseal System drug effects, Hypothalamo-Hypophyseal System metabolism, Male, Maze Learning drug effects, Maze Learning physiology, Morphine pharmacology, Neural Pathways metabolism, Pain metabolism, Pain physiopathology, Pain Measurement drug effects, Raphe Nuclei drug effects, Raphe Nuclei metabolism, Rats, Vocalization, Animal drug effects, Vocalization, Animal physiology, Anxiety drug therapy, Brain drug effects, Morphine Derivatives pharmacology, Narcotics pharmacology, Neural Pathways drug effects, Pain drug therapy, Serotonin metabolism
- Abstract
We have studied the effects of 14-methoxymetopon (HS 198), a potent opioid agonist, on the responses to the tail electric stimulation test and plus-maze activity of adult male rats. The prototype mu agonist morphine was used as the drug of reference. Besides we addressed the effects of HS 198 on the serum corticosterone levels and on serotonergic systems of discrete brain regions. Both drugs were administered subcutaneously. Morphine (5 mg/kg) and HS 198 (30 microg/kg) induced a similar effect on the nociceptive test, with both drugs significantly increasing the threshold for the vocalization afterdischarge, which is related to the emotional component of pain. In the plus-maze, morphine (5 mg/kg) and HS 198 (20 and 30 microg/kg) induced similar increases in the percentages of entries and time in the open arms, two parameters related to the anxiety state of the animals. The results indicate that HS 198 is far more potent than morphine in reducing the emotive/affective component of pain and in inducing an anxiolytic effect. HS 198 (30 microg/kg) also induced parallel increases in the serum corticosterone levels and the hypothalamic serotonin content. A possible correlation between the anxiolytic action of the drug and its effect on the hypothalamic serotonergic system is suggested.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.